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Roaming wild: Tigers are among those species that may become extinct in the wild, even 
though their survival in captivity is assured. By engaging in education and conservation work, 
zoos can help to make sure that this situation does not become a more widespread phenom-
enon. The picture shows a Bengal Tiger in Karnataka, India. (Photo: Karunakar Rayker.)in Phoenix, Arizona, USA, for instance, 
supports conservation projects in situ 
with its annual grants launched in 2009 
(http://phoenixzoo.org/conservation/
global-conservation/). In total, the 
more than 200 accredited members 
of the (US) Association of Zoos and 
Aquariums (AZA) spend over $160 
million each year on in situ conservation
initiatives based in countries around 
the world (https://www.aza.org/
conservation-funding/). 
Bristol Zoo (UK) has recently 
completed a fundraising appeal to 
save 750 abandoned African penguin 
chicks, which were then successfully 
reintroduced into the wild. This 
species is endangered to the point 
that saving individual chicks is of 
crucial importance for its survival. In a
press statement, Christoph Schwitzer,
Director of Conservation at Bristol 
Zoological Society, said: “Unless 
conservation charities such as us 
intervene, these chicks would starve 
to death. We wanted to help so we 
launched an urgent appeal. Recent 
research shows that penguin chicks 
hand-reared at the rescue centre in 
South Africa survive and reproduce 
just as well as those naturally reared, 
when reintroduced back into the 
wild. We would like to say a massive 
thankyou to all those who supported R394 Current Biology 25, R391–R408, Mathe appeal — the money raised will 
literally help to save a species.” In 
situations like these, captive animals 
can serve as ambassadors to 
motivate people to help saving their 
conspecifics in the wild. 
Outlook
Given that wildlife attractions tend to 
attract not only millions of visitors but 
also a lot of media attention as well as 
the critical gaze of just about anybody 
who worries about the relations 
between humans and animals, they 
too may have to adapt to the times of 
climate change and biodiversity loss. 
In the future, taxpayers and visitors 
may demand that the zoos and 
aquariums prove their claims that they 
are doing good deeds for humans and 
animals alike, beyond the traditional 
mission of just offering access to 
wildlife for entertainment. 
Nobody would want the zoos and 
aquariums to become repositories of 
numerous species labelled ‘extinct 
in the wild’. So the challenge for all 
these institutions is to find their role in 
helping the animals that are still wild 
and free. 
Michael Gross is a science writer based at 
Oxford. He can be contacted via his web page 
at www.michaelgross.co.uk
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Alcino Silva is a Professor in the 
Departments of Neurobiology, 
Psychiatry, and Psychology and 
Director of the Integrative Center for 
Learning and Memory at the University 
of California in Los Angeles. He was 
one of the pioneers of the field of 
Molecular and Cellular Cognition, 
and in 2002 founded and became 
the first President of the Molecular 
and Cellular Cognition Society. 
His laboratory has made seminal 
contributions to learning and memory 
mechanisms, including the discovery 
of memory allocation mechanisms in 
neuronal networks. His laboratory has 
also developed treatments in mice 
for learning and memory disorders, 
including neurofibromatosis type I and 
tuberous sclerosis. Recently, he was 
awarded the Order of Prince Henry, 
a MERIT award from the NIA, the 
Senior Roche Award for Translational 
Neuroscience, and became a fellow 
of the American Association for the 
Advancement of Science. 
Why did you decide to become 
a neuroscientist? I grew up in 
Portugal, and the standard high 
school curriculum there included 
philosophy courses. Although I have 
long forgotten most of what I learned, 
an age-old epistemology question 
stayed with me all of these years: 
“how can we be sure of what we 
know?” This question fascinated me 
because the answer could potentially 
affect every single aspect of human 
existence, including every single 
discovery in science. For example, 
how can we be sure of anything 
we learn, if we do not understand 
how our brains acquire, process 
and store information? Perhaps, all 
human knowledge could be biased 
by the peculiarities of our brains, 
which were designed to survive the 
wilderness of Africa. It is unlikely that 
evolution optimized our neurobiology 
for grasping physics, chemistry or 
biology! When I had an opportunity to 
come and study in the USA, I took it 
without hesitation, and the rest of my 
life seemed to follow its course the 
moment I landed in Kennedy Airport 
in the summer of 1978… 
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the question that motivated you 
to become a neuroscientist? I like 
to believe that every experiment 
that I have ever done as a scientist 
has ultimately targeted that one 
question one way or the other. I 
decided to do my PhD work with 
Raymond White because I believed 
that the then new field of human 
genetics would provide a strong 
anchor into brain mechanisms of 
learning and memory. While I was 
a graduate student, I learned about 
Mario Capecchi’s revolutionary 
molecular genetics work with mice, 
and immediately decided to use 
knock-out mice to study molecular 
and cellular mechanisms of learning. 
This technology completely 
changed neuroscience from a 
discipline of many silos — molecular 
neurobiology, neurophysiology, 
systems neuroscience, 
behavioral neuroscience, and 
so on — to a more integrated 
discipline, where explanations of 
behavioral phenomena included 
multidisciplinary studies with 
molecular, neurophysiological, 
and behavioral components. For 
example, in Susumu Tonegawa’s 
lab, I targeted a synaptic kinase, 
the alpha calmodulin kinase II, 
and with Charles Stevens lab at 
the Salk and Jeanne Wehner’s 
lab at the University of Colorado, 
we were able to show that this 
synaptic kinase is critical for long-
term changes in synaptic strength 
and for learning in mice! In my own 
laboratory, I continued to study 
not only learning, but also different 
phases of memory. For example, we 
showed that the transcription factor 
CREB is critical for both the stability 
of synaptic plasticity and memory 
in mice. Later on, we worked on the 
mechanisms responsible for remote 
memory, and showed that synaptic 
plasticity in neocortical networks 
is essential for this late phase of 
memory. So, this and related work 
from our lab and many other labs 
around the world has demonstrated 
that synaptic plasticity has a critical 
role in learning and memory, and 
by implication, that this form of cell 
biology must play a critical role in our
ability to learn about and radically 
transform the world around us. 
What about your studies of 
neurodevelopmental disorders such 
as neurofibromatosis type I and 
tuberous sclerosis — how does this 
work tie in to your epistemological 
quest? I realized that it was critical 
to connect the molecular, cellular 
and circuit mechanisms we were 
discovering in mice with cognitive 
processes in humans. My PhD years 
in Ray White’s lab taught me about 
the power of human genetics, and I 
realized that the study of mechanisms 
responsible for learning disorders 
could provide a bridge between 
our studies in mice and learning 
mechanism in humans. If we were 
successful in using mechanism-based 
treatments developed in mice to help 
patients, we would have a compelling 
bridge between studies of learning in 
mice and humans. And then, I met the 
families affected with these disorders 
and the work took on an entire new 
degree of urgency and importance 
for me. The idea that our work may 
one day help the millions of people 
around the world with NF1 and TSC 
is simply wonderful. I will never forget 
the first time we realized we had in 
our hands conclusive evidence that 
the learning deficits associated with 
NF1, a neurodevelopmental disorder 
that affects millions of people world-
wide, could be reversed in adult 
mice! That result changed the way 
we looked at this class of disorders, 
as many people were convinced that 
the only real hope was to intervene 
during development. Within a few 
years there were many other examples 
that reinforced the hope that adult 
treatments may actually be successful 
in neurodevelopmental disorders. 
Do you have any scientific heroes? 
Absolutely! I always feel chills up 
my spine when I see the prescient 
drawings that Ramon Cajal made of 
cellular networks in the cortex! Many 
people do not realize that the act of 
seeing in science is deeply creative. 
Cajal literally created many of our 
modern notions of cells and their 
possible functions in the brain. In my 
own field, the very models that guide 
our work to this day go back to ideas 
and hypotheses that Cajal proposed 
now more than 100 years ago! On the 
other end of this spectrum, I deeply 
admire many of the young people Current Biology 25, R391–R408, May 18, 2015 that worked with me over the years. 
It is hard when they leave the lab, but 
many times I felt like getting up in a 
meeting and bragging that so-and-so 
that just gave an amazing talk was 
once in my lab! 
You mentioned your students — 
what is the best advice you have 
ever been given? That would be what 
Jim Watson told me when I was setting 
up my own lab in Cold Spring Harbor 
laboratory. He told me that I should 
always surround myself with people 
that made me slightly uncomfortable 
because they were smarter than me. I 
loved that advice for several reasons. 
For one, it implied that laboratories 
should be intellectually open and 
rankless places, where ideas and 
ability, not hierarchy, should be first and 
foremost. 
What do you think is the single 
most important thing that could 
be done to accelerate our search 
for the biological mechanisms of 
cognitive function? To my mind, the 
answer is unequivocal. There is an 
enormous problem, a problem so large 
and serious that I think it is emerging 
as the single biggest impediment 
to real progress in the biological 
sciences, including neuroscience: 
we no longer can navigate the 
immensity of the published record and 
optimize research decisions! The size, 
complexity and interconnectedness 
of information in biology are growing 
at an unprecedented pace that 
urgently demand new tools and new ©2015 Elsevier Ltd All rights reserved R395
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Figure 1. A research map representing results from a research paper. 
Each node in the graph has three items that describe the name of the node (top), as well as spatial 
(middle) and temporal (bottom) information that defines it. Nodes are connected by edges that 
characterize the nature of the causal relations represented, including excitatory (sharp edges), 
inhibitory (dull edge) and no relation (dotted line). Hypothetical edges (in gray with no edge weights 
or symbols) reflect hypotheses that help to structure the data pictured in the graph. Each edge 
representing experiment(s) also has a score that reflects the amount of evidence supporting that 
connection, and symbols that reflect the types of experiments carried out, including an upward 
arrow for Positive Manipulations, a downward arrow for Negative Manipulations, and a triangle 
for Mediation Experiments (see text for definitions). This graph was generated by a free and open 
source web app (researchmaps.org).approaches. It is simply no longer 
possible for individual biologists to 
be aware of even a fraction of the 
published findings potentially pertinent 
to their work. The library of medicine, 
for example, now includes the results 
of more than an estimated 100 
million experiments. This number will 
probably double in the next ten years! 
Things do not get any better even at 
an individual level. In the last couple 
of years, for example, I read very 
carefully a couple of hundred research 
papers because they are directly and 
critically relevant to work in my lab. 
Those papers reported approximately 
two to three thousand experiments. I 
know that I have forgotten the majority 
of these experiments, and remember 
incorrectly or incompletely a scarily 
large number of them. I actually know 
this because of our researchmaps.org 
project, because I kept track of many 
of these experiments in a database. 
Even for this very limited research 
set, it is simply impossible for me, or 
anyone else for that matter, to reason 
systematically through all of those 
results, remember them with clarity 
and compute their implications! When 
the implications of what has already 
been published remain buried in the 
ever-growing size, complexity and 
interconnectedness of information in 
biology, how can scientists, like myself, 
reasonably optimize future research R396 Current Biology 25, R391–R408, Mayplans? The key is that biology has 
not always been this way: I remember 
that, as a student, biology was made 
up of disciplines that were like little 
self-sufficient islands of information, 
where individual scientists could master 
and remember most of the relevant 
information.
There is a great deal of work that 
tackles the big data problems you 
just described: what is your lab 
specifically doing in this area? 
We have developed graphical and 
interactive web tools — researchmaps, 
alluded to in the previous answer — 
that track, map and weight causal 
evidence. Although causal assertions 
are the very fabric of biology, 
there are currently no tools to 
help biologists keep track of the 
increasingly more complex network 
of causal connections derived from 
published findings. Simply put, the 
tools we engineered help biologists 
keep track of causal information. 
Importantly, the framework and 
principles used to build research 
maps, including convergency and 
consistency, reflect common practices 
in biology. It is important to stress that 
we did not invent these principles. 
We simply derived algorithms that 
capture their intent, and automated 
the process of systematically using 
them to map and manipulate causal  18, 2015 ©2015 Elsevier Ltd All rights reservedinformation. Because all of this is kept 
in interactive and graphical databases 
that preserve the provenance of each 
mapped experiment, it is a matter 
of a few key-strokes to get to either 
a graphical summary of any paper 
in the database, or to generate 
tailor made graphical summaries 
that combine specific experiments 
from any paper in the database. We 
have essentially build an app that 
biologists can use to keep track of 
important information, and that allows 
them to manipulate that information 
in ways that would be essentially 
impossible without it. The web app, 
researchmaps.org, that we engineered 
is an open source, completely free 
academic resource. The maps 
are easy to generate, combine, 
manipulate, query, and so on. 
What do research maps actually 
include? Research maps are 
simply networks where biological 
phenomena, their identity and 
properties (the nodes in the map) 
are linked by weighted causal 
connections, the edges in this network 
(Figure 1). These edges represent 
one of three possible types of causal 
connections between any two 
phenomena of interest: excitatory, 
where one phenomenon promotes 
the other; inhibitory, where one 
inhibits the other; or simply a lack of 
measurable effect of one on the other. 
Users can also include hypothetical 
edges in their maps. Amongst other 
things, hypothetical edges can help 
to organize information in the maps. 
A score from zero to one assigned to 
each edge gives users a sense of the 
strength and consistency of evidence 
represented by each connection 
among the phenomena represented. 
Additionally, symbols inform users of 
the types of experiments represented 
in each edge. 
Although there are tens of millions of 
experiments testing causal relations in 
biology — for example, between two 
phenomena A and B — they fall into 
four classes: Positive Manipulations, 
where A’s levels or activity are 
increased and the result measured 
on B; Negative Manipulations, when 
A’s levels or activity are decreased; 
Non-Interventions, the goal of which 
is to track how A co-varies with B; 
and Mediation experiments, designed 
Current Biology
Magazineto determine whether C is part of the 
mechanism by which A contributes 
to B. Biologists use convergency 
and consistency amongst these 
experiments to judge the strength 
of any causal assertion. Therefore, 
in research maps convergency and 
consistency amongst results increases 
the score assigned to each edge, while 
contradictory results have the opposite 
effect. By selecting any one edge in 
a particular research map, users can 
be directed to the exact experiments 
and associated research papers 
represented by that edge. Of course, 
there is much more to researchmaps, 
but this gives you a sense of what 
these maps are all about. 
Is this the theme of your recent 
book Engineering the Next 
Revolution in Neuroscience? I 
smile every time I read that title… 
It was intentionally provocative. 
Nevertheless, the problem we 
discuss in the book, the problem we 
tackle in our researchmaps project, 
is a big problem, and solving it will 
undoubtedly ‘revolutionize’ not 
only neuroscience, but perhaps any 
other field of science where causal 
information is key to progress. I know 
that this is a big claim, but it never 
pays to be shy about big problems. 
Beyond big data problems that 
individual neuroscientists face, the 
book also discusses the need for 
formal studies of how to optimize 
research planning. I dream of a 
time when scientific choice will be 
as rigorous and principle-based as 
algebra and geometry. This by no 
means excludes human creativity from 
the scientific process! No, it simply 
hones our creativity, focuses it onto 
those areas where it will be most 
useful and productive. The book really 
is about these and related themes. 
By the way: if we are ever to know 
how we learn and transform the world 
around us, we need formal tools like 
researchmaps to get there, and we 
may even need them to recognize that 
we have arrived.
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What is chromothripsis? The 
word ‘chromothripsis’ literally 
means ‘chromosome shattering’. 
Chromosomes that undergo 
chromothripsis first fragment into many 
pieces and then get stitched back 
together in a random order by DNA 
repair processes, most likely non-
homologous end joining. This generates 
a highly rearranged chromosome from 
a single catastrophic event (Figure 1). 
Previous complex chromosome 
rearrangements could be explained 
by multiple independent breakage 
and repair events accumulating on 
a chromosome over time. However, 
specific features of chromothripsis 
sequences — including highly 
clustered breakpoints, no segment 
amplification, and alternating retention 
and loss of heterozygosity along the 
chromosome — make it likely that the 
chromosome is breaking all at once. 
Currently, chromothripsis has been 
identified in cancer cells and in the 
male germline.
Why haven’t I heard about this 
before? Chromothripsis was 
discovered fairly recently by paired-
end sequencing in chronic lymphocytic 
leukemia. A mixture of whole genome 
sequencing, array-based comparative 
genomic hybridization (aCGH), and 
single nucleotide polymorphism 
(SNP) array analyses have now 
identified these massive chromosome 
rearrangements in many types 
of cancer. These data uncovered 
an unanticipated amount of small 
chromosome rearrangements and 
renewed interest in how chromosome 
structural variation contributes to 
cancer development. 
Several types of ‘all-at-once’ 
chromosome rearrangement processes, 
including chromothripsis, have now 
been described. Chromoanasynthesis 
looks very similar to chromothripsis 
in that it often affects a single 
chromosome or chromosome arm, but 
is characterized by the amplification of 
numerous segments and has signatures 
of replication-mediated repair. 
Quick guideCurrent Biology 25, R391–R408, May 18, 2015Chromoplexy occurs when multiple 
DNA breaks are present throughout 
the genome at one time and each end 
of each break finds a different partner 
to pair with during DNA repair. This 
results in the joining of many distant 
loci and chromosomes together. The 
term ‘chromoanagenesis’ (chromosome 
rebirth) has been proposed to 
describe these new types of complex 
chromosome rearrangements.
How bad is chromothripsis? In tumor 
cells chromothripsis has been shown to 
result in the loss of tumor suppressors 
and dysregulation of genes with known 
cancer links. In addition, shattering 
can cause oncogene amplification. 
Chromosome segments that fail to 
get reincorporated into the main 
chromosome can circularize to 
become double minutes. These small 
DNA circles are frequently amplified 
and, if oncogenes such as MYC are 
present within the double minutes, 
they become massively upregulated. 
Because chromothripsis affects a 
large number of genes at once, it can 
bypass the time delay inherent in the 
gradual accumulation of mutations and 
quickly stimulate cancer development 
or evolution. Consistent with this, 
chromothripsis is associated with poor 
prognosis in several cancer types (e.g. 
neuroblastoma), although it is unclear 
whether this is a causal link.
The flip side of affecting a large 
number of genes at once is that most 
chromothripsis events are going to be 
lethal. Significant misregulation of gene 
expression, loss of heterozygosity, 
and increased aneuploidy as a result 
of segments being lost are likely to be 
detrimental to the cell, regardless of 
which particular sequences are hit. This 
point is clear from examples of germline 
chromothripsis. Patients with congenital 
disease due to chromothripsis typically 
have few rearrangements and have 
retained almost all of the chromosome 
pieces. In cancer, chromothripsis has 
been correlated with loss of pathways 
that stabilize genome stability, such as 
inactivation of p53. In addition, cancer 
cells often undergo changes, such as 
an increase in ploidy, that can buffer the 
deleterious effects of aneuploidy and 
thus could generate an environment in 
which the benefits of highly rearranged 
chromosomes can outweigh the 
negative consequences.  ©2015 Elsevier Ltd All rights reserved R397
